Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Epelsiban in Healthy Female Volunteers
Clinical trial NCT02257359 · COMPLETED
Trial details
- NCT number
- NCT02257359
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-12-18
- Primary completion
- 2015-01-29
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.